MPS Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 27, 2025, 12:54 pm

Quick Insight

MPS Ltd, a key player in the IT Training Services sector, currently trades at a price of 2,151 with a market cap of 3,679 Cr. The company's P/E ratio stands at 33.0, indicating investor confidence in future earnings growth. With an impressive ROE of 30.1% and ROCE of 39.5%, MPS Ltd demonstrates efficient capital utilization and strong profitability. A healthy OPM of 34% further underscores operational efficiency. Notably, the company's ICR of 211.26x reflects robust debt-servicing capabilities. Despite a high P/BV of 5.70x, MPS Ltd's strong financial position, evident from reserves of 333 Cr and minimal borrowings of ₹4 Cr, positions it well for sustained growth and value creation in the competitive IT training industry.

Competitors of MPS Ltd

All Competitor Stocks of MPS Ltd

Quarterly Result

Last Updated: August 1, 2025, 4:50 pm

Below is a detailed analysis of the quarterly data for MPS Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 6.00 Cr..
• For Expenses, as of Jun 2025, the value is 65.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 59.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 6.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 34.00 Cr.. The value appears to be declining and may need further review. It has decreased from 35.00 Cr. (Mar 2025) to 34.00 Cr., marking a decrease of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 34.00%. The value appears to be declining and may need further review. It has decreased from 37.00% (Mar 2025) to 34.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
• For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 36.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 2.00 Cr..
• For Tax %, as of Jun 2025, the value is 24.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 24.00%.
• For Net Profit, as of Jun 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 2.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 16.81. The value appears strong and on an upward trend. It has increased from 16.03 (Mar 2025) to 16.81, marking an increase of 0.78.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:21 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 2:23 pm

Below is a detailed analysis of the balance sheet data for MPS Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 17.00 Cr..
• For Reserves, as of Mar 2025, the value is 333.00 Cr.. The value appears to be declining and may need further review. It has decreased from 354.00 Cr. (Mar 2024) to 333.00 Cr., marking a decrease of 21.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 4.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 41.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.00 Cr. (Mar 2024) to 41.00 Cr., marking an increase of 7.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 395.00 Cr.. The value appears to be improving (decreasing). It has decreased from 408.00 Cr. (Mar 2024) to 395.00 Cr., marking a decrease of 13.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 69.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 69.00 Cr..
• For CWIP, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Mar 2025, the value is 136.00 Cr.. The value appears to be declining and may need further review. It has decreased from 148.00 Cr. (Mar 2024) to 136.00 Cr., marking a decrease of 12.00 Cr..
• For Other Assets, as of Mar 2025, the value is 187.00 Cr.. The value appears to be declining and may need further review. It has decreased from 190.00 Cr. (Mar 2024) to 187.00 Cr., marking a decrease of 3.00 Cr..
• For Total Assets, as of Mar 2025, the value is 395.00 Cr.. The value appears to be declining and may need further review. It has decreased from 408.00 Cr. (Mar 2024) to 395.00 Cr., marking a decrease of 13.00 Cr..

Notably, the Reserves (333.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for MPS Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 70.01. This value is within the healthy range. It has increased from 63.87 (Mar 23) to 70.01, marking an increase of 6.14.
• For Diluted EPS (Rs.), as of Mar 24, the value is 69.96. This value is within the healthy range. It has increased from 63.87 (Mar 23) to 69.96, marking an increase of 6.09.
• For Cash EPS (Rs.), as of Mar 24, the value is 81.11. This value is within the healthy range. It has increased from 75.23 (Mar 23) to 81.11, marking an increase of 5.88.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 268.81. It has increased from 247.69 (Mar 23) to 268.81, marking an increase of 21.12.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 268.81. It has increased from 247.69 (Mar 23) to 268.81, marking an increase of 21.12.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 318.78. It has increased from 292.91 (Mar 23) to 318.78, marking an increase of 25.87.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 106.46. This value is within the healthy range. It has increased from 97.94 (Mar 23) to 106.46, marking an increase of 8.52.
• For PBIT / Share (Rs.), as of Mar 24, the value is 94.78. This value is within the healthy range. It has increased from 86.54 (Mar 23) to 94.78, marking an increase of 8.24.
• For PBT / Share (Rs.), as of Mar 24, the value is 94.27. This value is within the healthy range. It has increased from 85.89 (Mar 23) to 94.27, marking an increase of 8.38.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 69.43. This value is within the healthy range. It has increased from 63.83 (Mar 23) to 69.43, marking an increase of 5.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 69.43. This value is within the healthy range. It has increased from 63.83 (Mar 23) to 69.43, marking an increase of 5.60.
• For PBDIT Margin (%), as of Mar 24, the value is 33.39. This value is within the healthy range. It has decreased from 33.43 (Mar 23) to 33.39, marking a decrease of 0.04.
• For PBIT Margin (%), as of Mar 24, the value is 29.73. This value exceeds the healthy maximum of 20. It has increased from 29.54 (Mar 23) to 29.73, marking an increase of 0.19.
• For PBT Margin (%), as of Mar 24, the value is 29.57. This value is within the healthy range. It has increased from 29.32 (Mar 23) to 29.57, marking an increase of 0.25.
• For Net Profit Margin (%), as of Mar 24, the value is 21.78. This value exceeds the healthy maximum of 10. It has decreased from 21.79 (Mar 23) to 21.78, marking a decrease of 0.01.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 21.78. This value exceeds the healthy maximum of 20. It has decreased from 21.79 (Mar 23) to 21.78, marking a decrease of 0.01.
• For Return on Networth / Equity (%), as of Mar 24, the value is 25.82. This value is within the healthy range. It has increased from 25.77 (Mar 23) to 25.82, marking an increase of 0.05.
• For Return on Capital Employeed (%), as of Mar 24, the value is 30.69. This value is within the healthy range. It has decreased from 33.22 (Mar 23) to 30.69, marking a decrease of 2.53.
• For Return On Assets (%), as of Mar 24, the value is 16.12. This value is within the healthy range. It has decreased from 19.79 (Mar 23) to 16.12, marking a decrease of 3.67.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.84. It has decreased from 0.95 (Mar 23) to 0.84, marking a decrease of 0.11.
• For Current Ratio (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has decreased from 3.36 (Mar 23) to 1.61, marking a decrease of 1.75.
• For Quick Ratio (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has decreased from 3.36 (Mar 23) to 1.61, marking a decrease of 1.75.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 72.81. This value exceeds the healthy maximum of 50. It has increased from 46.99 (Mar 23) to 72.81, marking an increase of 25.82.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 62.32. This value exceeds the healthy maximum of 50. It has increased from 39.87 (Mar 23) to 62.32, marking an increase of 22.45.
• For Earning Retention Ratio (%), as of Mar 24, the value is 27.19. This value is below the healthy minimum of 40. It has decreased from 53.01 (Mar 23) to 27.19, marking a decrease of 25.82.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 37.68. This value is below the healthy minimum of 40. It has decreased from 60.13 (Mar 23) to 37.68, marking a decrease of 22.45.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 211.26. This value is within the healthy range. It has increased from 151.23 (Mar 23) to 211.26, marking an increase of 60.03.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 138.78. This value is within the healthy range. It has increased from 99.57 (Mar 23) to 138.78, marking an increase of 39.21.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,503.96. It has increased from 1,669.61 (Mar 23) to 2,503.96, marking an increase of 834.35.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.59. This value exceeds the healthy maximum of 3. It has increased from 3.33 (Mar 23) to 4.59, marking an increase of 1.26.
• For EV / EBITDA (X), as of Mar 24, the value is 13.75. This value is within the healthy range. It has increased from 9.97 (Mar 23) to 13.75, marking an increase of 3.78.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.80. This value exceeds the healthy maximum of 3. It has increased from 3.65 (Mar 23) to 4.80, marking an increase of 1.15.
• For Retention Ratios (%), as of Mar 24, the value is 27.18. This value is below the healthy minimum of 30. It has decreased from 53.00 (Mar 23) to 27.18, marking a decrease of 25.82.
• For Price / BV (X), as of Mar 24, the value is 5.70. This value exceeds the healthy maximum of 3. It has increased from 4.31 (Mar 23) to 5.70, marking an increase of 1.39.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.80. This value exceeds the healthy maximum of 3. It has increased from 3.65 (Mar 23) to 4.80, marking an increase of 1.15.
• For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.04, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness